[Eczematous reactions following internal uptake of contact allergens].
D000284:Administration, Oral; D000328:Adult; D000485:Allergens / Q000008:administration & dosage*; D001153:Arsphenamine / Q000009:adverse effects / Q000031:analogs & derivatives; D001391:Azo Compounds / Q000009:adverse effects; D002648:Child; D002840:Chromates / Q000009:adverse effects; D003875:Drug Eruptions; D004485:Eczema / Q000139:chemically induced*; D005029:Ethylenediamines / Q000009:adverse effects; D005260:Female; D005503:Food Additives / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D008297:Male; D008670:Metals / Q000009:adverse effects; D009355:Neomycin / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D011804:Quinolines / Q000009:adverse effects / Q000031:analogs & derivatives; D012008:Recurrence; D012882:Skin Tests; D013307:Streptomycin / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013831:Thiamine / Q000009:adverse effects
D000485:Allergens; D001391:Azo Compounds; D002840:Chromates; D005029:Ethylenediamines; D005503:Food Additives; D006634:Histamine H1 Antagonists; D008670:Metals; D010640:Phenothiazines; D011804:Quinolines; D013449:Sulfonamides; D001153:Arsphenamine; D009355:Neomycin; D013831:Thiamine; D013307:Streptomycin
Ekzematöse Reaktionen bei innerlicher Aufnahme von Kontaktallergenen